Skip to content
Menu

Oscar Health, Inc. OSCR

Full chart Compare
Set alert

Price alert · OSCR

All alert types
31.05 USD -0.89 (-2.79%)

Regular-session close

30.87 -0.18 -0.58%

After hours · Nov 13, 6:59 PM ET

29.82 Day range 32.40
10.85 52-week range 35.19
YTD
+116.08%
1 year
+122.58%
Market cap
9.65B
Revenue (ttm)
17.47B
Profit margin
4.90%
EPS (ttm)
2.25
Shares out
275.51M
P/E ratio
13.80
Forward P/E
12.67
YTD return
+116.08%
1-year return
+122.58%
Volume
4.85M
Avg volume
5.27M
Open
32.03
Previous close
31.94
Day's range
29.82 – 32.40
52-week range
10.85 – 35.19
Beta
2.49
Analysts
Hold
Price target
37.00 (+19.2%)
Earnings date
Feb 9, 2027

5D -0.69 (-2.17%)

303234MonTueWedThuFri31.05

Key statistics

Enterprise value
2.91B
PEG ratio
0.00
Price / sales
0.55
Price / book
4.34
Dividend yield
0.00%
Payout ratio
0.00%
Revenue growth
72.10%
Free cash flow
1.73B
Total cash
7.49B
Total debt
481.73M
Return on equity
52.62%
Short % of float
6.57%
50-day average
32.02
200-day average
24.35

Fundamental scorecard

15 of 25 checks passed on OSCR’s reported financials

Value: 2/5ValueGrowth: 4/5GrowthProfitability: 4/5ProfitabilityFinancial health: 5/5HealthDividend: 0/5Dividend

15of 25 checks passed

  • Value 2 of 5
  • Growth 4 of 5
  • Profitability 4 of 5
  • Financial health 5 of 5
  • Dividend 0 of 5

Statements to Sep 30, 2026.

Financials — quick view

All financials
OSCR Revenue — quarterly 5.14B
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
OSCR Net income — quarterly 167.28M
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026
OSCR EPS — quarterly 0.54
2022-Q4 20222023-Q1 20232023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20242024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20252025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20262026-Q2 20262026-Q3 2026

Earnings

OSCR recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 9, 2027Dec 30, 2026-1.08———
Nov 5, 2026Sep 30, 2026-0.143820.49+0.63+440.70%
Aug 6, 2026Jun 30, 20260.4031.10+0.70+172.95%
May 6, 2026Mar 31, 20261.212.07+0.86+71.07%
Feb 10, 2026Dec 31, 2025-0.9214-1.24-0.32-34.58%
Nov 6, 2025Sep 30, 2025-0.55-0.53+0.02+3.64%

Upgrades / downgrades

OSCR analyst upgrades and downgrades
DateFirmActionFromTo
Nov 6, 2026Piper SandlermainOverweightOverweight
Oct 12, 2026UBSmainNeutralNeutral
Sep 18, 2026Raymond JamesmainOutperformOutperform
Sep 17, 2026B of A SecuritiesmainUnderperformUnderperform
Sep 17, 2026Stephens & Co.reitEqual-WeightEqual-Weight
Sep 17, 2026BarclaysmainOverweightOverweight

About Oscar Health, Inc.

Oscar Health, Inc. operates as a healthcare technology company in the United States. The company offers health plans to individuals, families, employees, and small group markets. It also provides +Oscar platform that power others throughout the healthcare system; Campaign Builder platform, an engagement and recommendation platform for providers and payors; and reinsurance products. In addition, the company offers brokerage services and enrollment platform for brokers and consumers to shop, buy, and enroll in medical and supplemental health products. The company was formerly known as Mulberry Health Inc. and changed its name to Oscar Health, Inc. in January 2021. Oscar Health, Inc. was incorporated in 2012 and is headquartered in New York, New York.

Sector
Healthcare
Industry
Healthcare Plans
Country
United States
Website
hioscar.com

News

Your note

Sign in to keep a note on OSCR — it syncs with the Stock Master app.

Insider holders

OSCR insider holders
InsiderRelationLatest transactionDateShares held
BERTOLINI MARK TChief Executive OfficerSaleJun 29, 20267,751,570
BLACKLEY RICHARD SCOTTChief Financial OfficerSaleSep 2, 20261,102,360
BOPITIYA RANMALI WOODYOfficerSaleDec 1, 2024241,488
BOYD JEFFERY HDirectorStock Award(Grant)Jun 3, 2025705,673
KUSHNER JOSHUAOfficer, Director and Beneficial OwnerPurchaseNov 20, 20240
LIANG JANETOfficerSaleSep 2, 2026248,697

Institution ownership

OSCR institution ownership
Holder% heldSharesValueReported
Blackrock Inc.7.47%20,587,428639.34MJun 29, 2026
T. Rowe Price Investment Management, Inc.4.73%13,035,486404.82MJun 29, 2026
Shaw D.E. & Co., Inc.4.59%12,643,617392.65MJun 29, 2026
Vanguard Portfolio Management LLC4.00%11,029,424342.52MJun 29, 2026
Vanguard Capital Management LLC3.84%10,579,437328.54MJun 29, 2026
FMR, LLC3.27%8,998,716279.46MSep 29, 2026

Fund ownership

OSCR fund ownership
Holder% heldSharesValueReported
VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund2.76%7,599,713236.01MJun 29, 2026
iShares Trust-iShares Russell 2000 ETF2.28%6,283,032195.12MSep 29, 2026
American Century ETF Trust-Avantis U.S. Small Cap Value ETF2.16%5,944,429184.60MSep 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Index Fund1.99%5,490,151170.50MJun 29, 2026
VANGUARD INDEX FUNDS-Vanguard Small-Cap Growth Index Fund1.15%3,163,64798.25MJun 29, 2026
T. Rowe Price Small-Cap Stock Fund, Inc.1.11%3,055,64294.89MJun 29, 2026